What question did this study set out to answer?

This research characterizes uropathogen distribution and their antimicrobial resistance patterns from 2019 to 2024.

Distribution and antimicrobial resistance of uropathogens: a 6-year retrospective single-center study (2019–2024)

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis uncovers antimicrobial resistance patterns in uropathogens, indicating treatment adjustments are needed.

This research characterizes uropathogen distribution and their antimicrobial resistance patterns from 2019 to 2024.
Retrospective analysis of clinical urine specimens (N=1,978)
Pathogen identification using VITEK MS system
Antimicrobial susceptibility testing via VITEK-2 system and Kirby-Bauer method
E. coli showed 35.1% prevalence and low resistance to nitrofurantoin; high resistance to ampicillin and fluoroquinolones is observed.
Carbapenem resistance in K. pneumoniae peaked at 59.4% in 2020, with fluctuating rates over the study period.
Recommendation to avoid fluoroquinolones and ampicillin as first-line agents while endorsing nitrofurantoin and amikacin for E. coli.

Wu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark